Auswahl der wissenschaftlichen Literatur zum Thema „Legionnaires' disease“

Geben Sie eine Quelle nach APA, MLA, Chicago, Harvard und anderen Zitierweisen an

Wählen Sie eine Art der Quelle aus:

Machen Sie sich mit den Listen der aktuellen Artikel, Bücher, Dissertationen, Berichten und anderer wissenschaftlichen Quellen zum Thema "Legionnaires' disease" bekannt.

Neben jedem Werk im Literaturverzeichnis ist die Option "Zur Bibliographie hinzufügen" verfügbar. Nutzen Sie sie, wird Ihre bibliographische Angabe des gewählten Werkes nach der nötigen Zitierweise (APA, MLA, Harvard, Chicago, Vancouver usw.) automatisch gestaltet.

Sie können auch den vollen Text der wissenschaftlichen Publikation im PDF-Format herunterladen und eine Online-Annotation der Arbeit lesen, wenn die relevanten Parameter in den Metadaten verfügbar sind.

Zeitschriftenartikel zum Thema "Legionnaires' disease"

1

Saks, Mark. „Legionnairesʼ Disease Not Just For Legionnaires Anymore“. Emergency Medicine News 28, Nr. 1 (Januar 2006): 6–8. http://dx.doi.org/10.1097/00132981-200601000-00016.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
2

Gould, Dinah. „Legionnaires’ disease“. Nursing Standard 17, Nr. 45 (23.07.2003): 41–44. http://dx.doi.org/10.7748/ns2003.07.17.45.41.c3423.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
3

Gould, Dinah. „Legionnaires’ disease“. Nursing Standard 17, Nr. 45 (23.07.2003): 41–44. http://dx.doi.org/10.7748/ns.17.45.41.s55.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
4

Prozorovsky, S. V., V. I. Pokrovsky und I. S. Tartakovsky. „Legionnaires' disease“. Kazan medical journal 66, Nr. 6 (15.12.1985): 464. http://dx.doi.org/10.17816/kazmj62258.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
5

Davis, Gerald S., und Washington C. Winn. „Legionnaires' Disease:“. Clinics in Chest Medicine 8, Nr. 3 (September 1987): 419–39. http://dx.doi.org/10.1016/s0272-5231(21)01038-8.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
6

Sandeep, K. R., und B. S. Sandhya Rani. „Legionnaires ’Disease“. International Journal of Nursing Education and Research 6, Nr. 4 (2018): 439. http://dx.doi.org/10.5958/2454-2660.2018.00106.0.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
7

Fallon, R. J. „Legionnaires' Disease“. Scottish Medical Journal 39, Nr. 5 (Oktober 1994): 135–37. http://dx.doi.org/10.1177/003693309403900502.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
8

BUSSEN, SELENA V. „Legionnaires' Disease“. Radiology 194, Nr. 2 (Februar 1995): 406. http://dx.doi.org/10.1148/radiology.194.2.406.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
9

PORTER, RICHARD T. „Legionnaires' Disease“. Radiology 195, Nr. 3 (Juni 1995): 638. http://dx.doi.org/10.1148/radiology.195.3.638.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
10

Brundrett, Geoffrey. „Legionnaires’ disease“. Journal of the Royal Society for the Promotion of Health 122, Nr. 3 (September 2002): 146–47. http://dx.doi.org/10.1177/146642400212200308.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen

Dissertationen zum Thema "Legionnaires' disease"

1

De, Goveia C. „Legionella infections : a review of the literature and a prospective serological study of the incidence of Legionnaires disease at Groote Schuur Hospital“. Master's thesis, University of Cape Town, 1989. http://hdl.handle.net/11427/25585.

Der volle Inhalt der Quelle
Annotation:
A prospective study of patients with pneumonia admitted to Groote Schuur Hospital took place over a one-year period in an attempt to assess the incidence of legionella pneumonia. Acute and convalescent serum samples were obtained from 113 patients. Eight patients (7,1%) showed a fourfold rise in antibody titre against Legionella pneumophila group 1 antigen by indirect immunofluorescent test (IFAT). The findings suggest that legionella pneumonia, although not common, should be considered in the aetiology of pneumonia at Groote Schuur Hospital. The results are presented and a review of the literature is undertaken.
APA, Harvard, Vancouver, ISO und andere Zitierweisen
2

IJzerman, E. P. F. „Progress in diagnostics and prevention of Legionnaires' disease“. [S.l. : [Groningen : s.n.] ; University Library Groningen] [Host], 2009. http://irs.ub.rug.nl/ppn/315954442.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
3

Doyle, Robyn Michelle. „Molecular analysis of Legionella longbeachae serogroup 1 virulence“. Title page, contents and summary only, 2000. http://web4.library.adelaide.edu.au/theses/09PH/09phd7546.pdf.

Der volle Inhalt der Quelle
Annotation:
Bibliography: leaves 246-304. Describes experiments aimed at characterising the potential virilant factors of Legionella longbeachae sg 1, an important human pathogen which is responsible for nearly half of all clinical cases of Legionella related pneumonia reported each year.
APA, Harvard, Vancouver, ISO und andere Zitierweisen
4

Sakamoto, Ryota. „Is driving a car a risk for Legionnaires' disease?“ Kyoto University, 2009. http://hdl.handle.net/2433/126450.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
5

Bhopal, Rajinder Singh. „Geographic variation in the incidence of Legionnaires' disease in Scotland“. Thesis, University of Edinburgh, 1991. http://hdl.handle.net/1842/26329.

Der volle Inhalt der Quelle
Annotation:
The major sources of infection for Legionnaire's Disease, identified by study of outbreaks, are hot water systems and cooling towers. However, most cases are not part of outbreaks and, for these, the source of infection is rarely traced. The principal aim of this study was to help understand the source of non-outbreak infection by examining the epidemiology of the disease in Scotland. Of the recognized cases which met the study case-definition, 366 were ill between 1978 to 1986 giving a mean annual incidence rate of 7.9 per million. The annual incidence varied in Scotland (range 3.1 to 20.2) and within health boards. Geographical variations were demonstrated by health board, by city and within cities, particularly for non-travel infection. For example, the cumulative incidence rate per million for non-travel, non-outbreak disease in Greater Glasgow Health Board (GGHB) was 130 compared to 45 for the whole of Scotland, and 11, 33 and 50 in Tayside, Lanarkshire and Lothian Health Boards respectively. Of 16 postcode sectors with a high incidence of disease in Scotland, 14 were in GGHB. In GGHB, the residence of non-travel, non-outbreakcases (but not of travel-related ones) was clustered in central areas. Previously unrecognised clustering was also found in other health boards. These variations were not fully explained by differences in the population's exposure to diagnostic tests, as indicated by the number of serology tests requested by Scottish hospitals; the diagnostic service and approach of bacteriology laboratories; and the approach of hospital consultants to the diagnosis of Legionnaires' Disease. Differences in host susceptibility, as reflected by socio-economic status and the incidence of other respiratory disease, were small and did not explain the variation. In the City of Glasgow, many cooling towers were not maintained in accord with recommendations and posed a theoretical risk of infection. The location of residence of non-travel cases was associated with the location of premises with cooling towers, the incidence of non-travel Legionnaires' Disease being more than three times higher in areas of Glasgow within 0.5 kilometres of a cooling tower than in areas more than one kilometre away. The best explanation for these observations is that cooling towers were a major source of non-travel, non-outbreak infection. Hence, for the investigation and prevention of such infection, the emphasis should be on cooling tower maintenance. Close surveillance of apparently sporadic disease is recommended as the basis for disease control and future research.
APA, Harvard, Vancouver, ISO und andere Zitierweisen
6

Fry, Norman Kenneth. „Analysis of the ribosomal RNA genes of the family Legionellaceae for classification and identification“. Thesis, London School of Hygiene and Tropical Medicine (University of London), 1992. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.315280.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
7

Boswell, Timothy Charles John. „The serological crossreaction between legionella and campylobacter“. Thesis, King's College London (University of London), 1997. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.267616.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
8

Wilmot, Peter Nicholas. „Modelling cooling tower risk for Legionnaires' Disease using Bayesian Networks and Geographic Information Systems“. Title page, contents and conclusion only, 1999. http://web4.library.adelaide.edu.au/theses/09SIS.M/09sismw744.pdf.

Der volle Inhalt der Quelle
Annotation:
Includes bibliographical references (leaves 115-120) Establishes a Bayesian Belief Network (BBN) to model uncertainty of aerosols released from cooling towers and Geographic Information Systems (GIS) to create a wind dispersal model and identify potential cooling towers as the source of infection. Demonstrates the use of GIS and BBN in environmental epidemiology and the power of spatial information in the area of health.
APA, Harvard, Vancouver, ISO und andere Zitierweisen
9

James, Brian William. „Nutrient availability modulating physiology and pathogenicity of Legionella pneumophila“. Thesis, Open University, 1997. http://oro.open.ac.uk/57693/.

Der volle Inhalt der Quelle
Annotation:
A virulent strain of Legionella pneumophila serogroup 1 was established in continuous culture under defined iron-replete conditions at pH 6.9. Iron-limitation and extremes of pH (6.0 and 7.8) influenced the growth and metabolism of L. pneumophila, as manifested by increased metabolic activity, impaired energy coupling, and altered metabolic fluxes. In particular, the physiological versatility of L. pneumophila was demonstrated by a significant decrease in the iron content of biomass (6-fold increase in Yiron), coupled with reduced metabolic efficiency (Y, on), in response to iron-limited growth. Iron limitation promoted the accumulation of significant intracellular reserves of poly- ß-hydroxybutyrate (16 % cell dry wt.), which supported long-term survival of L. pneumophila under starvation conditions. Expression of the important pathogenicity factor, the zinc metalloprotease, was regulated by iron availability. Common iron acquisition mechanisms, such as siderophores and transferrin receptors, were not elaborated by iron-limited cells. However, human transferrin was identified as a potential iron source for L. pneumophila, with the zinc metalloprotease mediating transferrin digestion and possibly iron acquisition. Iron-limitation and extremes of pH also influenced cellular morphology and the surface properties of L. pneumophila, promoting the formation of uniform cultures of short rod-shaped bacteria, with altered fatty acid, phospholipid and protein composition. In addition to morphological and physiological adaptation, iron limitation had a significant effect on the virulence of L. pneumophila. Iron-replete cells grown at pH 6.9 and 6.0 were highly virulent in a guinea pig model. However, the virulence of L. pneumophila was significantly attenuated (P < 0.05) in response to iron-limited growth. This phenomenon was reversible, and correlated with reduced phagocytosis and / or reduced intracellular survival following infection. Decreasing the pH of iron-limited cultures to 6.0 did not stimulate recovery of culture virulence. Therefore, this study clearly demonstrates that environmental stresses, including iron limitation and extremes of pH, play an important role in modulating the physiology and virulence of L. pneumophila, inducing the expression of distinct phenotypes differing in their ability to persist in nature and cause infection.
APA, Harvard, Vancouver, ISO und andere Zitierweisen
10

Ricketts, Katherine. „The influence of environmental factors on sporadic cases of Legionnaires disease in England and Wales“. Thesis, London School of Hygiene and Tropical Medicine (University of London), 2011. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.549779.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen

Bücher zum Thema "Legionnaires' disease"

1

Zonderman, Jon. Legionnaires' disease. Philadelphia: Chelsea House Publishers, 2005.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
2

executive, Health and safety. Legionnaires' disease. London: H.M.S.O., 1987.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
3

Brundrett, G. W. Engineering aspects of legionnaires disease. Chester: Electricity Council Research Centre, 1986.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
4

Great Britain. Expert Advisory Committee on Biocides. Report of the Expert Advisory Committee on Biocides. London: H.M.S.O., 1989.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
5

Uzel, Atac. Legionella pneumophila: From environment to disease. Hauppauge, N.Y: Nova Science Pub., 2010.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
6

Centers for Disease Control (U.S.), Hrsg. Pseudoepidemic of Legionnaires' disease, Philadelphia, Pennsylvania. Atlanta, [Ga.]: Public Health Service, CDC, 1985.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
7

Chartered Institution of Building Services Engineers., Hrsg. Minimising the risk of Legionnaires' disease. London: Chartered Institution of Building Services Engineers, 1991.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
8

M, Barbaree James, Hrsg. Legionellae control in health care facilities: A guide for minimizing risk. Indianapolis, IN: HC Information Resources, 1996.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
9

Atac, Uzel, und Hames-Kocabas E. Esin, Hrsg. Legionella pneumophila: From environment to disease. Hauppauge, N.Y: Nova Science Pub., 2009.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
10

Centers for Disease Control (U.S.), Hrsg. Hospital-laboratory diagnosis of legionella infections. Atlanta, Ga: U.S. Dept. of Health and Human Services, Public Health Service, Centers for Disease Control, 1987.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen

Buchteile zum Thema "Legionnaires' disease"

1

Cianciotto, Nicholas P., Hubert Hilbi und Carmen Buchrieser. „Legionnaires’ Disease“. In The Prokaryotes, 147–217. Berlin, Heidelberg: Springer Berlin Heidelberg, 2013. http://dx.doi.org/10.1007/978-3-642-30144-5_94.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
2

Jia, Cuiyu, Dawei Zhao und Jianan Yu. „Legionnaires’ Disease“. In Radiology of Infectious Diseases: Volume 2, 121–30. Dordrecht: Springer Netherlands, 2015. http://dx.doi.org/10.1007/978-94-017-9876-1_12.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
3

Roig, J., M. Sabria und X. Castella. „Legionnaires’ Disease“. In Infectious Diseases in Critical Care, 404–12. Berlin, Heidelberg: Springer Berlin Heidelberg, 2007. http://dx.doi.org/10.1007/978-3-540-34406-3_37.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
4

Kreutner, A. Karen. „Legionnaires’ Disease“. In Principles of Medical Therapy in Pregnancy, 480–81. Boston, MA: Springer US, 1985. http://dx.doi.org/10.1007/978-1-4613-2415-7_64.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
5

Lucas, Claressa E., und Barry S. Fields. „Legionellaeand Legionnaires' Disease“. In Manual of Environmental Microbiology, 3.2.9–1–3.2.9–13. Washington, DC, USA: ASM Press, 2015. http://dx.doi.org/10.1128/9781555818821.ch3.2.9.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
6

Roig, Jorge, und Jordi Rello. „Treatment of Legionnaires' Disease“. In Legionella, 8–14. Washington, DC, USA: ASM Press, 2014. http://dx.doi.org/10.1128/9781555815660.ch02.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
7

Brown, Andrew S., Ian R. van Driel und Elizabeth L. Hartland. „Mouse Models of Legionnaires’ Disease“. In Current Topics in Microbiology and Immunology, 271–91. Berlin, Heidelberg: Springer Berlin Heidelberg, 2013. http://dx.doi.org/10.1007/82_2013_349.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
8

Berrington, William R., und Thomas R. Hawn. „Human Susceptibility to Legionnaires’ Disease“. In Methods in Molecular Biology, 541–51. Totowa, NJ: Humana Press, 2012. http://dx.doi.org/10.1007/978-1-62703-161-5_33.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
9

Brune, Michelle. „Legionnaires' Disease and Water Systems“. In Architectural Factors for Infection and Disease Control, 65–77. New York: Routledge, 2022. http://dx.doi.org/10.4324/9781003214502-6.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
10

Sipahioglu, Hilal, und Faruk Seçkin Yücesoy. „Noninvasive Ventilation in Legionnaires’ Disease“. In Noninvasive Mechanical Ventilation in High Risk Infections, Mass Casualty and Pandemics, 207–12. Cham: Springer International Publishing, 2023. http://dx.doi.org/10.1007/978-3-031-29673-4_23.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen

Konferenzberichte zum Thema "Legionnaires' disease"

1

Muscedere, D., S. Sahni, Y. Malyshev, G. K. Upadhya und R. Cofsky. „Making It Mental - Neurological Manifestations of Legionnaires’ Disease“. In American Thoracic Society 2019 International Conference, May 17-22, 2019 - Dallas, TX. American Thoracic Society, 2019. http://dx.doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a3691.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
2

Isaac, A. G. „Legionnaires Disease Manifesting as an Acute Leukemoid Reaction“. In American Thoracic Society 2023 International Conference, May 19-24, 2023 - Washington, DC. American Thoracic Society, 2023. http://dx.doi.org/10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a5651.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
3

Hanna, S., I. Milojevic und H. Patel. „Cerebellar Symptoms: An Uncommon Presentation of Legionnaires' Disease“. In American Thoracic Society 2022 International Conference, May 13-18, 2022 - San Francisco, CA. American Thoracic Society, 2022. http://dx.doi.org/10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a4500.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
4

Cysneiros, Ana, Francisca Lopes, Joao Carvalho, Patricia Dionisio, Christine Costa, Bruno Von Amann, Ana Dias et al. „Legionella score performance under an outbreak of Legionnaires' disease“. In Annual Congress 2015. European Respiratory Society, 2015. http://dx.doi.org/10.1183/13993003.congress-2015.pa2576.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
5

Saradna, A., R. Kunadharaju, B. Bahl, M. Ahmad und M. Saeed. „Legionnaires' Disease Associated Secondary Hemophagocytic Lymphohistiocytosis and Erythema Multiforme“. In American Thoracic Society 2021 International Conference, May 14-19, 2021 - San Diego, CA. American Thoracic Society, 2021. http://dx.doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a3970.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
6

Branco, Joana, Carlos Macedo, Nelson Marçal, Ana Alves, Catarina Pissarra und Paula Rosa. „Pneumology outpatient clinic's role during an outbreak of Legionnaires' disease“. In ERS International Congress 2016 abstracts. European Respiratory Society, 2016. http://dx.doi.org/10.1183/13993003.congress-2016.pa2582.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
7

Mengiste, H. A., M. Jindal, Y. Gebrekidan und A. Mehari. „A Case of Legionnaires' Disease Associated with Massive Gastrointestinal Bleeding“. In American Thoracic Society 2020 International Conference, May 15-20, 2020 - Philadelphia, PA. American Thoracic Society, 2020. http://dx.doi.org/10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a6896.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
8

Yosry, N., A. Chajkowski, C. Rodriguez, Y. Medik, M. Lali, S. Qaiser und W. Khan. „A Rare Cause of Rhabdomyolysis and Acute Renal Failure: Legionnaires Disease“. In American Thoracic Society 2024 International Conference, May 17-22, 2024 - San Diego, CA. American Thoracic Society, 2024. http://dx.doi.org/10.1164/ajrccm-conference.2024.209.1_meetingabstracts.a6011.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
9

Nunez Cuello, L., D. Bhattarai und B. Matta. „Inhaling Trouble: Legionnaires' Disease Secondary to Cannabis Smoking With a Bong“. In American Thoracic Society 2024 International Conference, May 17-22, 2024 - San Diego, CA. American Thoracic Society, 2024. http://dx.doi.org/10.1164/ajrccm-conference.2024.209.1_meetingabstracts.a4163.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
10

Kumar, D., D. Kumar, Z. Khan und M. Bachan. „A Rare Case of Rhabdomyolysis and Renal Failure Secondary to Legionnaires Disease“. In American Thoracic Society 2020 International Conference, May 15-20, 2020 - Philadelphia, PA. American Thoracic Society, 2020. http://dx.doi.org/10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a3907.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen

Berichte der Organisationen zum Thema "Legionnaires' disease"

1

Tyndall, R. L., S. W. Christensen und J. A. Solomon. Legionnaires' disease bacteria in power plant cooling systems: Phase 2. Office of Scientific and Technical Information (OSTI), April 1985. http://dx.doi.org/10.2172/5732566.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
2

Health hazard evaluation report: evaluation of Legionnaires' disease risk and other health hazards at an offset printing company. U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, April 2016. http://dx.doi.org/10.26616/nioshhhe201500653252.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
3

Health hazard evaluation report: HETA-2011-0109-3162, Legionnaires' disease at an automobile and scrap metal shredding facility, New York. U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, August 2012. http://dx.doi.org/10.26616/nioshheta201101093162.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
Wir bieten Rabatte auf alle Premium-Pläne für Autoren, deren Werke in thematische Literatursammlungen aufgenommen wurden. Kontaktieren Sie uns, um einen einzigartigen Promo-Code zu erhalten!

Zur Bibliographie
Current page language: German.
You might want to see the page in this language: English.
Change language